Poster
Oligonucleotides for CNS 2025—Optimized Dried Blood Microsampling Extraction Coupled with Hybridization LC-MS/MS for the Sensitive Quantitation of Antisense Oligonucleotides
Oligonucleotides for CNS 2025—Surrogate CSF for the Bioanalysis of Oligonucleotide Therapeutics Through LBA
Strategy for Addressing Specificity Challenges in Quantitation of Etonogestrel in Human Plasma by LC-MS/MS
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs
Practical Considerations for the Evaluation of Physical Dependence and Drug Withdrawal for Novel CNS-Active Drugs in Clinical Trials
Navigating the Unchartered Territory of Assessing Psychedelics in Human Abuse Potential Studies
Gene Therapy Studies and Germline Integration Assessment in Nonhuman Primates
Geographic Atrophy-Like Induced Model in Nanopigs
Evaluation in Canines of a Novel Device for Suprachoroidal Drug Delivery
Background Data in the Sinclair Nanopig™